Literature DB >> 12562304

An evaluation of current cholera treatment.

Sujit Kumar Bhattacharya1.   

Abstract

Cholera, caused by Vibrio cholerae O1 and O139, is characterised by profuse purging of watery stools, and vomiting and dehydration. The mainstay of therapy of cholera patients is rehydration with oral rehydration salt solution or intravenous Ringer's lactate depending upon the degree of dehydration. Antibiotics such as tetracycline, doxycycline, norfloxacin, ciprofloxacin and furazolidone may be used as an adjunct to rehydration therapy for severely purging cholera patients to reduce the rate of stool output. This shortens the duration of hospital stay, stops excretion of vibrios in the stool and minimises the requirement of fluids. Resistance to many of these drugs has been observed and is a matter of concern. Other antidiarrhoeals are not recommended. Many antisecretory drugs have been tried as an adjunct therapy, unfortunately, until today, none has been found useful in the treatment of cholera. Feeding during and after cholera is emphasised.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12562304     DOI: 10.1517/14656566.4.2.141

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  5 in total

Review 1.  Natural-Product-Based Solutions for Tropical Infectious Diseases.

Authors:  Oyelola Adegboye; Matt A Field; Andreas Kupz; Saparna Pai; Dileep Sharma; Michael J Smout; Phurpa Wangchuk; Yide Wong; Claire Loiseau
Journal:  Clin Microbiol Rev       Date:  2021-09-08       Impact factor: 50.129

2.  Antibiotic susceptibility profiles of some Vibrio strains isolated from wastewater final effluents in a rural community of the Eastern Cape Province of South Africa.

Authors:  Anthony I Okoh; Etinosa O Igbinosa
Journal:  BMC Microbiol       Date:  2010-05-14       Impact factor: 3.605

Review 3.  Vibrio fluvialis: an unusual enteric pathogen of increasing public health concern.

Authors:  Etinosa O Igbinosa; Anthony I Okoh
Journal:  Int J Environ Res Public Health       Date:  2010-10-12       Impact factor: 3.390

4.  Vaxchora: The First FDA-Approved Cholera Vaccination in the United States.

Authors:  Juan F Mosley; Lillian L Smith; Patricia Brantley; Dustin Locke; Madison Como
Journal:  P T       Date:  2017-10

Review 5.  Vibrio Pathogenicity Island-1: The Master Determinant of Cholera Pathogenesis.

Authors:  Ashok Kumar; Bhabatosh Das; Niraj Kumar
Journal:  Front Cell Infect Microbiol       Date:  2020-10-06       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.